Mercury Laboratories Limited (BOM:538964)
India · Delayed Price · Currency is INR 750.00
-48.00 (-6.02%)
At close: Nov 6, 2026
Mercury Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 737.65 | 759.37 | 751.01 | 755.59 | 753.34 | 579.24 |
Other Revenue | -5.41 | - | - | - | - | - |
| 732.23 | 759.37 | 751.01 | 755.59 | 753.34 | 579.24 | |
Revenue Growth | -5.37% | 1.11% | -0.61% | 0.30% | 30.06% | -15.57% |
Cost of Revenue | 298.92 | 311.77 | 303.9 | 324.27 | 328.94 | 247.77 |
Gross Profit | 433.31 | 447.6 | 447.11 | 431.32 | 424.39 | 331.46 |
Selling, General & Admin | 177.99 | 174.37 | 168.41 | 145.01 | 142.45 | 124.97 |
Other Operating Expenses | 184.99 | 178.95 | 205.14 | 192.71 | 189 | 134.96 |
Operating Expenses | 394.77 | 387.51 | 402.31 | 365.88 | 361.11 | 284.6 |
Operating Income | 38.54 | 60.08 | 44.8 | 65.44 | 63.28 | 46.87 |
Interest Expense | -1.78 | -1.7 | -2.16 | -0.65 | -0.57 | -1.7 |
Interest & Investment Income | 1.02 | 1.02 | 0.94 | 1.2 | 1.24 | 0.88 |
Currency Exchange Gain (Loss) | 11.66 | 11.66 | 4.46 | 3.55 | 12.4 | 4.31 |
Other Non Operating Income (Expenses) | -0.75 | -0.75 | -1.95 | -1.01 | -1.63 | -1.52 |
EBT Excluding Unusual Items | 48.7 | 70.32 | 46.09 | 68.53 | 74.71 | 48.84 |
Gain (Loss) on Sale of Assets | - | - | 0.53 | 0.68 | -0.27 | 0.23 |
Other Unusual Items | -3.95 | -3.95 | - | - | - | 1.28 |
Pretax Income | 44.75 | 66.37 | 46.62 | 69.2 | 74.45 | 50.34 |
Income Tax Expense | 12.81 | 18.03 | 15.17 | 12.66 | 18.66 | 14.73 |
Net Income | 31.94 | 48.34 | 31.45 | 56.54 | 55.79 | 35.62 |
Net Income to Common | 31.94 | 48.34 | 31.45 | 56.54 | 55.79 | 35.62 |
Net Income Growth | -35.00% | 53.71% | -44.38% | 1.35% | 56.62% | -33.27% |
Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 |
Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 |
Shares Change | -0.01% | - | - | - | - | - |
EPS (Basic) | 26.61 | 40.28 | 26.21 | 47.12 | 46.49 | 29.68 |
EPS (Diluted) | 26.61 | 40.28 | 26.21 | 47.12 | 46.49 | 29.68 |
EPS Growth | -35.00% | 53.70% | -44.38% | 1.35% | 56.64% | -33.27% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 6.39 | 10.75 | -41.82 | 19.53 | 13.96 | 32.74 |
Free Cash Flow Per Share | 5.33 | 8.96 | -34.85 | 16.28 | 11.63 | 27.29 |
Dividend Per Share | - | 3.500 | 3.500 | 3.500 | 3.500 | 3.500 |
Dividend Growth | - | 0% | 0% | 0% | 0% | 0% |
Gross Margin | 59.18% | 58.94% | 59.53% | 57.08% | 56.34% | 57.22% |
Operating Margin | 5.26% | 7.91% | 5.96% | 8.66% | 8.40% | 8.09% |
Profit Margin | 4.36% | 6.37% | 4.19% | 7.48% | 7.41% | 6.15% |
Free Cash Flow Margin | 0.87% | 1.42% | -5.57% | 2.58% | 1.85% | 5.65% |
EBITDA | 63.53 | 87.48 | 67.26 | 86.61 | 84.14 | 67.39 |
EBITDA Margin | 8.68% | 11.52% | 8.96% | 11.46% | 11.17% | 11.63% |
D&A For EBITDA | 24.99 | 27.39 | 22.46 | 21.17 | 20.86 | 20.52 |
EBIT | 38.54 | 60.08 | 44.8 | 65.44 | 63.28 | 46.87 |
EBIT Margin | 5.26% | 7.91% | 5.96% | 8.66% | 8.40% | 8.09% |
Effective Tax Rate | 28.62% | 27.17% | 32.54% | 18.30% | 25.06% | 29.25% |
Revenue as Reported | 751.79 | 778.92 | 761.7 | 766.48 | 770.53 | 587.4 |